Literature DB >> 11092397

Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females.

E Damien1, J S Price, L E Lanyon.   

Abstract

Mechanical strain, testosterone, and estrogen all stimulate proliferation of primary cultures of male rat long bone (LOB)-derived osteoblast-like cells as determined by [3H]thymidine incorporation. The maximum proliferative effect of a single period of mechanical strain (3400 microepsilon, 1 Hz, and 600 cycles) is additional to that of testosterone (10(-8) M) or estrogen (10(-8) M). The cells' proliferative response to strain is abolished both by concentrations of tamoxifen that cause proliferation (10(-8) M) and by those that have no effect (10(-6) M). Strain-related proliferation also is reduced by the estrogen antagonist ICI 182,780 (10(-8) M) but is unaffected by the androgen receptor antagonist hydroxyflutamide (10(-7) M). Tamoxifen, ICI 182,780, and the aromatase inhibitor 4-dihydroandrostenedione, at concentrations that have no effect on basal proliferation, significantly reduce the proliferative effect of the aromatizable androgen testosterone but not that of the nonaromatizable androgen 5alpha-dihydrotestosterone. Hydroxyflutamide, at a concentration that has no effect on basal proliferation (10(-7) M), eliminates the proliferative effect of 5alpha-dihydro-testosterone but had no significant effect on that caused by testosterone. Proliferation associated with strain is blocked by neutralizing antibody to insulin-like growth factor II (IGF-II) but not by antibody to IGF-I. Proliferation associated with testosterone is blocked by neutralizing antibody to IGF-I but is unaffected by antibody to IGF-II. These data suggest that in rat osteoblast-like cells from males, as from females, strain-related proliferation is mediated through the estrogen receptor (ER) in a manner that does not compete with estrogen but that can be blocked by ER modulators. Proliferation associated with testosterone appears to follow its aromatization to estrogen and is mediated through the ER, whereas proliferation associated with 5alpha-dihydrotestosterone is mediated by the androgen receptor. Strain-related proliferation in males, as in females, is mediated by IGF-II, whereas proliferation associated with estrogen and testosterone is mediated by IGF-I.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092397     DOI: 10.1359/jbmr.2000.15.11.2169

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  35 in total

1.  Effect of prior treatment with resveratrol on density and structure of rat long bones under tail-suspension.

Authors:  Caroline Habold; Iman Momken; Ali Ouadi; Virgile Bekaert; David Brasse
Journal:  J Bone Miner Metab       Date:  2010-05-11       Impact factor: 2.626

Review 2.  Effects of androgen replacement on metabolism and physical performances in male hypogonadism.

Authors:  M Zitzmann; E Nieschlag
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 3.  Impact of mechanical stretch on the cell behaviors of bone and surrounding tissues.

Authors:  Hye-Sun Yu; Jung-Ju Kim; Hae-Won Kim; Mark P Lewis; Ivan Wall
Journal:  J Tissue Eng       Date:  2015-12-29       Impact factor: 7.813

Review 4.  Loading and bone fragility.

Authors:  Ego Seeman
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

Review 5.  Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.

Authors:  Shoshana Yakar; Olle Isaksson
Journal:  Growth Horm IGF Res       Date:  2015-09-28       Impact factor: 2.372

Review 6.  WNT Signaling in osteoarthritis and osteoporosis: what is the biological significance for the clinician?

Authors:  Liesbet Lodewyckx; Rik J U Lories
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

Review 7.  Men, bone and estrogen: unresolved issues.

Authors:  E S Orwoll
Journal:  Osteoporos Int       Date:  2003-03-04       Impact factor: 4.507

8.  Estrogen receptor alpha CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women.

Authors:  B M H Lai; C L Cheung; K D K Luk; A W C Kung
Journal:  Osteoporos Int       Date:  2007-09-26       Impact factor: 4.507

9.  Cancellous bone properties and matrix content of TGF-beta2 and IGF-I in human tibia: a pilot study.

Authors:  Yener N Yeni; X Neil Dong; Bingbing Zhang; Gary J Gibson; David P Fyhrie
Journal:  Clin Orthop Relat Res       Date:  2009-05-27       Impact factor: 4.176

10.  Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 receptor-independent activation of beta-catenin signaling.

Authors:  Andrew Sunters; Victoria J Armstrong; Gul Zaman; Robert M Kypta; Yoshiaki Kawano; Lance E Lanyon; Joanna S Price
Journal:  J Biol Chem       Date:  2009-12-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.